4//SEC Filing
BARDON CHRISTIANA 4
Accession 0001209191-18-040539
CIK 0001566373other
Filed
Jul 2, 8:00 PM ET
Accepted
Jul 3, 8:59 AM ET
Size
7.4 KB
Accession
0001209191-18-040539
Insider Transaction Report
Form 4
BARDON CHRISTIANA
Director10% Owner
Transactions
- Award
Common Stock
2018-07-02+824→ 1,465 total
Holdings
- 54,824(indirect: By Burrage Capital Healthcare Fund I, LP)
Common Stock
- 833,839(indirect: By UBS Oncology Impact Fund)
Common Stock
Footnotes (3)
- [F1]Pursuant to the Issuer's Non-Employee Director Compensation Policy, the shares on this Form 4 were automatically issued to the Reporting Person, who previously elected to take shares in lieu of cash compensation for services as a director and committee member of the Issuer.
- [F2]The Reporting Person's spouse is the Managing Member of MPM Oncology Impact Management GP LLC, an indirect General Partner of UBS Oncology Impact Fund L.P. ("Oncology Impact Fund"). Dr. Bardon disclaims beneficial ownership of the securities held by Oncology Impact Fund, except to the extent of her or her spouse's pecuniary interest therein, and the inclusion of these securities in the report shall not be deemed an admission of beneficial ownership of the securities for the purposes of Section 16 or for any other purpose.
- [F3]The Reporting Person is the Portfolio Manager of Burrage Capital Healthcare Fund I, L.P. ("Burrage Capital"). Dr. Bardon disclaims beneficial ownership of the securities held by Burrage Capital, except to the extent of her pecuniary interest therein, and the inclusion of these securities in the report shall not be deemed an admission of beneficial ownership of the securities for the purposes of Section 16 or for any other purpose.
Documents
Issuer
Spring Bank Pharmaceuticals, Inc.
CIK 0001566373
Entity typeother
Related Parties
1- filerCIK 0001717679
Filing Metadata
- Form type
- 4
- Filed
- Jul 2, 8:00 PM ET
- Accepted
- Jul 3, 8:59 AM ET
- Size
- 7.4 KB